Medical societies have publicly condemned PMI’s Vectura purchase. NEW YORK — A coalition of health care organizations from around the world have issued a joint statement noting their concern about Philip Morris International’s (PMI) recent acquisition of biotech firm Vectura. Vectura is a world leader in developing inhaled pharmacological therapies for respiratory diseases. Throughout much … Continue reading ATS: PMI Buying Vectura is Bad News